Welcome to the Connect Ovar Coffee Information Series, the show that brings you hope and inspires you to embrace the spirit of OVARCOMING!
Connect Ovar Coffee is an education, awareness, and empowerment driven podcast. Each month, we deliver the latest & greatest information on progress and advances in ovarian cancer screening, diagnosis, treatment, and survivorship. The information shared by our Experts in this Series apply widely to the entire spectrum of ovarian cancer experience.
We invite you to Connect Ovar Coffee with us!
Maintaining Optimal Health & Well Being in Ovarcoming in Ovarian Cancer: Dr. Renee Stubbins
Listen, download, subscribe, and SHARE our Connect Ovar Coffee Podcast here:
We hope you enjoyed watching or listening to our Connect Ovar Coffee episodes! Please leave us with your comment, or suggestions.
Topic: Granulosa Cell Tumors, What You Should Know
Guest: Dr. Tyler Hillman, Associate Professor, University of California, San Diego
“Be involved. Stay connected. You are not alone.”
Topic: Innovations in Ovarian and Gynecologic Cancers
Guest: Dr. Elizabeth Swisher, Professor & Director of Gynecologic Oncology, Fred Hutch
Topic: Oncology Nutrition, Lifestyle Wellness, and Cancer Recovery
Guest: Dr. Renee Stubbins, Oncology Dietitian, Houston Methodist
“Eat your fruits and vegetables, stay active, and get lots of rest and sunlight.”
Topic: Compassionate Cancer Care, Survivorship, and Innovations in Treatment
Guest: Dr. Erin Stevens, Surgical Oncologist, Prevea Health
Topic: Surgical Advances, Prevention, and Personalized Care in Gynecologic Cancers
Guest: Dr. Kara Long, Surgeon & Oncologist, Memorial Sloan Kettering Cancer Center
Surgical Innovations
Topic: Ovarian Cancer Recurrence, Innovation, and Patient Support
Guest: Dr. Marta Crispens, Director of Gyn Oncology, Vanderbilt Ingram Cancer Center
Ovarian Cancer is Heterogeneous: High-grade serous carcinoma differs from low-grade; requires personalized treatment.
Recurrence Causes:
Drug Resistance Factors:
Immunotherapy Challenges:
Emerging Solutions:
Targeted Therapies:
Desensitization for Drug Allergies:
PARP Inhibitors:
Side Effect Management:
Emotional Navigation:
Support Clinical Trials:
Advocacy:
“More isn’t always better—but balance is.”— Dr. Marta Crispens
Topic: CA125, Early Detection, and Innovative Therapies for Ovarian Cancer
Guest: Dr. Robert Bast, Co-Founder of CA125 and Leading World Renowned Oncologist